Showing results (111-120 of 156) with videos related to
Sort By:
Pageof 16
International Journal of Cancer|December 21, 2004
ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomasYoshinao Oda, Tsuyoshi Saito, Naomi Tateishi, et al.The Journal of Biological Chemistry|November 4, 2006
YB-1 is important for an early stage embryonic development: neural tube formation and cell proliferationTakeshi Uchiumi, Abbas Fotovati, Takakazu Sasaguri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinomaMahmut Yasen, Kazunori Kajino, Sayaka Kano, et al.The Prostate|June 1, 2018
Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamideMasaki Shiota, Naohiro Fujimoto, Katuyoshi Higashijima, et al.Endocrine-Related Cancer|August 28, 2015
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancerMasaki Shiota, Momoe Itsumi, Ario Takeuchi, et al.Bioscience Reports|April 24, 2024
Cardiomyocyte-specific deletion of the mitochondrial transporter Abcb10 causes cardiac dysfunction via lysosomal-mediated ferroptosisYura Do, Mikako Yagi, Haruka Hirai, et al.Cancer Science|April 19, 2016
Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2Momoe Itsumi, Masaki Shiota, Ario Takeuchi, et al.European Journal of Oral Sciences|April 19, 2016
Dihydroorotate dehydrogenase depletion hampers mitochondrial function and osteogenic differentiation in osteoblastsJingXian Fang, Haruyoshi Yamaza, Takeshi Uchiumi, et al.Journal of Cellular Physiology|July 7, 2015
Grp78 Is Critical for Amelogenin-Induced Cell Migration in a Multipotent Clonal Human Periodontal Ligament Cell LineKyosuke Toyoda, Takao Fukuda, Terukazu Sanui, et al.Cancer Science|July 28, 2018
Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variantsMasaki Shiota, Takashi Dejima, Yoshiaki Yamamoto, et al.Pageof 16